Semax Spray is a research-use peptide formulation containing Semax, a synthetic heptapeptide associated with laboratory research into peptide signaling, neurobiology, receptor interactions, and molecular pathways. Semax is structurally related to the ACTH(4–10) peptide fragment and has been investigated in published scientific literature involving neuronal signaling and neurotrophin-related pathways. Helix Bio supplies research materials for qualified laboratory and scientific applications. Semax Spray is offered strictly for research use and is not intended for human or veterinary consumption, diagnosis, treatment, or prevention of disease.
HPLC certified
Independent analysis
Highest standard
Full traceability
Semax is a synthetic heptapeptide commonly identified by the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Scientific literature describes it as an analogue of the N-terminal fragment of adrenocorticotropic hormone, ACTH(4–10).
Research on Semax has examined its interaction with biological systems associated with neurobiology, including studies of peptide binding and neurotrophin-related signaling. Published experimental work has investigated Semax in cellular and animal models, including research involving brain-derived neurotrophic factor (BDNF) and related signaling pathways. These findings provide research context but should not be interpreted as evidence of clinical efficacy or as a medical recommendation.
A spray format can be relevant when researchers are studying intranasal peptide administration or comparing delivery approaches in controlled experimental models. Published research has specifically examined Semax following intranasal administration, making the route an established subject of experimental investigation.
For laboratory work, researchers should distinguish between the scientific literature surrounding Semax and the specifications of a particular commercial research material. Experimental results depend on factors such as peptide identity, purity, formulation, experimental model, analytical method, and study design.
Helix Bio positions its peptide catalog for research and laboratory purposes only. Product documentation and lot-specific analytical information should be reviewed before a material is incorporated into an experimental workflow.
Semax has been investigated in several areas of basic and translational research, including:
The existence of published research does not establish that Semax Spray is safe or effective for use in humans. Semax is not an FDA-approved drug in the United States, and regulatory status should be distinguished from scientific interest or experimental literature. FDA materials published in July 2026 also document regulatory consideration of Semax in the context of pharmacy compounding.
Researchers evaluating peptide materials generally need more than a product name. Identity, purity, analytical documentation, storage requirements, and traceability can all affect the interpretation of experimental results.
Helix Bio states that its research peptide catalog uses independent HPLC testing for purity assessment and mass spectrometry for molecular identity confirmation. The company also states that batch-specific Certificates of Analysis are available for its products.
For Semax Spray, researchers should verify the applicable product documentation and current lot information rather than relying solely on a general product description.
Semax Spray is intended for qualified users working in legitimate laboratory or scientific research environments, including:
The product is not intended for personal experimentation, self-administration, human consumption, veterinary use, or medical treatment.
| Specification | Details |
|---|---|
| Product Name | Semax Spray |
| Research Category | Cognitive & Neuro / Research Peptide |
| Compound | Semax |
| Chemical Class | Synthetic heptapeptide |
| Related Peptide | ACTH(4–10) analogue |
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro |
| Format | Spray formulation |
| Intended Use | Research and laboratory investigation only |
| Human Use | Not intended for human consumption |
| Veterinary Use | Not intended for veterinary use |
| Purity | Refer to current lot-specific product documentation |
| Identity Testing | Refer to applicable Certificate of Analysis |
| Packaging | Refer to current product listing |
| Storage | Follow current product-specific documentation |
| Manufacturer | Helix Bio |
| Country of Origin | Not specified; verify current product documentation |
Semax has a documented history of experimental investigation, particularly in neuroscience and peptide biology.
Researchers have investigated Semax in relation to neuronal signaling and neurotrophin-associated pathways. Experimental work has examined changes involving BDNF and TrkB signaling in animal models.
These studies can provide background for basic research into molecular signaling but should not be extrapolated directly into human therapeutic outcomes.
Semax is a synthetic heptapeptide related structurally to ACTH(4–10). Its defined amino-acid sequence makes it relevant to structure-function studies examining how peptide composition and molecular modifications influence biological interactions.
Semax has been investigated experimentally through intranasal administration, making the compound relevant to research examining peptide delivery routes and biological responses associated with intranasal experimental models.
Published studies have also examined Semax in cellular and biochemical systems, including work involving peptide-metal interactions and cellular assays.
Researchers should evaluate each publication according to its model, methodology, concentration, administration route, and endpoints rather than assuming that findings from one experimental system apply universally.
Analytical quality is important when working with research peptides because impurities, degradation products, incorrect identity, or inconsistent concentration can introduce unwanted variables into an experiment.
Helix Bio states that its peptide materials are subjected to independent HPLC testing for purity and mass spectrometry for molecular identity. It also states that batch-specific Certificates of Analysis are available for its products.
For a specific Semax Spray lot, researchers should consult the applicable COA and product documentation for the actual analytical results. A general catalog statement should not be treated as a substitute for lot-specific documentation.
Researchers should assess, where applicable:
No certification, regulatory approval, or quality claim should be inferred unless it is explicitly documented by the manufacturer or relevant regulatory authority.
Storage and handling requirements should be determined from the current Semax Spray product documentation and lot-specific instructions.
General laboratory considerations include:
Storage guidance should not be inferred from research protocols for other Semax preparations because formulation and packaging can affect stability.
Helix Bio's website describes research materials as being supplied to laboratories and institutions in the United States and describes tracked shipping and cold-chain handling within its fulfillment process.
Because shipping conditions, packaging specifications, availability, and delivery requirements may change, researchers should review the current Helix Bio shipping information and product listing before ordering.
Product packaging should remain appropriately labeled and handled as research material after delivery. Researchers are responsible for following applicable institutional, federal, state, and local requirements governing research materials.
Semax Spray is sold by Helix Bio for research and laboratory purposes only. It is not intended for human or veterinary consumption, self-administration, diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition.
Semax is not an FDA-approved drug in the United States. FDA approval status should not be inferred from published research, product availability, laboratory use, or any regulatory discussion concerning compounding. FDA explains that unapproved drugs have not undergone the agency's standard review for safety, effectiveness, and quality.
This product is not a dietary supplement, consumer wellness product, or medical treatment. Researchers are responsible for determining whether a material is appropriate for their intended experimental application and for complying with applicable institutional and regulatory requirements.
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
What bacteriostatic water contains, how it differs from sterile water and saline, where the 28-day opened-vial figure comes from, and what a COA can show.
Do you need a prescription for peptides? It depends on the category. See which peptides need one, which do not, and the dated 2026 FDA rules that apply.
The complete 2026 list of FDA-approved peptides: 47 drugs by category and approval year, which popular peptides are not approved, and pipeline to watch.
